Share This

Related Topics News -

     
 < Previous page   Title only   |   Print 
     
《盈警》福森藥業收益下跌 半年轉虧最少3,000萬人民幣

2024-08-21T  
福森藥業甲磺酸多沙唑秦緩釋片上市申請獲受理

2024-08-09T  
福森藥業創新藥臨床試驗申請獲受理

2024-07-14T  
福森藥業「恩扎盧胺軟膠囊」上市許可申請獲受理

2024-05-31T  
福森藥業複合磷酸氫鉀注射液上市申請獲受理

2024-04-24T  
福森藥業出資8,500萬人民幣組有限合夥企業

2024-04-17T  
福森藥業「二甲雙胍恩格列淨片(I)」上市申請獲受理

2024-04-04T  
《公司業績》福森藥業全年虧損擴至3,628萬人民幣

2024-04-02T  
《盈警響號》福森藥業研發增加 年度仍蝕至少3,500萬人民幣

2024-03-17T  
 < Previous page 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.